Management of Recurrent Gastrointestinal Stromal Tumors

被引：15
作者：
Winer, Joshua H. [1 ,2 ]
Raut, Chandrajit P. [1 ,2 ,3 ]
机构：
[1] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Dana Farber Canc Inst, Ctr Sarcoma & Bone Oncol, Boston, MA 02115 USA
来源：
JOURNAL OF SURGICAL ONCOLOGY | 2011年 / 104卷 / 08期
关键词：
recurrent gastrointestinal stromal tumor; imatinib mesylate; sunitinib malate; surgery; neoadjuvant therapy; blood level testing; PHASE-II TRIAL; IMATINIB MESYLATE; SURGICAL RESECTION; RESIDUAL DISEASE; TYROSINE-KINASE; DOSE IMATINIB; GIST; THERAPY; SURGERY; KIT;
D O I：
10.1002/jso.21890
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recurrence after resection of primary gastrointestinal stromal tumor (GIST) is an unfortunately all-too-common phenomenon. The principal treatment for recurrent GIST is the first-line tyrosine kinase inhibitor (TKI) imatinib mesylate. Those who progress on, or are intolerant of imatinib, are treated with second-line TKI sunitinib malate. Cytoreductive surgery may be considered as an "adjuvant" therapy for patients with disease stabilized on imatinib, and, on an individual basis, sunitinib. J. Surg. Oncol. 2011;104:915-920. (C) 2011 Wiley Periodicals, Inc.
引用
收藏
页码：915 / 920
页数：6
相关论文
共 44 条
  • [11] Bui BN, 2007, J CLIN ONCOL, V25
  • [12] Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib:: a centre-based study of 17 patients
    Bümming, P
    Andersson, J
    Meis-Kindblom, JM
    Klingenstierna, H
    Engström, K
    Stierner, U
    Wängberg, B
    Jansson, S
    Ahlman, H
    Kindblom, LG
    Nilsson, B
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (03) : 460 - 464
  • [13] Malignant Gastrointestinal Stromal Tumors of the Small Intestine: A Review of 50 Cases From a Prospective Database
    Jacqueline A. Crosby
    Charles N. Catton
    Aileen Davis
    Jean Couture
    Brian O’Sullivan
    Rita Kandel
    Carol J. Swallow
    [J]. Annals of Surgical Oncology, 2001, 8 (1) : 50 - 59
  • [14] Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)
    DeMatteo, Ronald P.
    Gold, Jason S.
    Saran, Lisa
    Goenen, Mithat
    Liau, Kui Hin
    Maki, Robert G.
    Singer, Samuel
    Besmer, Peter
    Brennan, Murray F.
    Antonescu, Cristina R.
    [J]. CANCER, 2008, 112 (03) : 608 - 615
  • [15] Results of tyrosine-kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor
    DeMatteo, Ronald P.
    Maki, Robert G.
    Singer, Samuel
    Gonen, Mithat
    Brennan, Murray F.
    Antonescu, Cristina R.
    [J]. ANNALS OF SURGERY, 2007, 245 (03) : 347 - 352
  • [16] Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival
    DeMatteo, RP
    Lewis, JJ
    Leung, D
    Mudan, SS
    Woodruff, JM
    Brennan, MF
    [J]. ANNALS OF SURGERY, 2000, 231 (01) : 51 - 58
  • [17] Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
    Demetri, GD
    von Mehren, M
    Blanke, CD
    Van den Abbeele, AD
    Eisenberg, B
    Roberts, PJ
    Heinrich, MC
    Tuveson, DA
    Singer, S
    Janicek, M
    Fletcher, JA
    Silverman, SG
    Silberman, SL
    Capdeville, R
    Kiese, B
    Peng, B
    Dimitrijevic, S
    Druker, BJ
    Corless, C
    Fletcher, CDM
    Joensuu, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) : 472 - 480
  • [18] Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
    Demetri, George D.
    van Oosterom, Allan T.
    Garrett, Christopher R.
    Blackstein, Martin E.
    Shah, Manisha H.
    Verweij, Jaap
    McArthur, Grant
    Judson, Ian R.
    Heinrich, Michael C.
    Morgan, Jeffrey A.
    Desai, Jayesh
    D Fletcher, Christopher
    George, Suzanne
    Bello, Carlo L.
    Huang, Xin
    Baum, Charles M.
    Casali, Paolo G.
    [J]. LANCET, 2006, 368 (9544) : 1329 - 1338
  • [19] Demetri GD, 2010, J NATL COMPR CANC NE, V8, pS1
  • [20] A Phase I Study of Single-Agent Nilotinib or in Combination with Imatinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors
    Demetri, George D.
    Casali, Paolo G.
    Blay, Jean-Yves
    von Mehren, Margaret
    Morgan, Jeffrey A.
    Bertulli, Rossella
    Ray-Coquard, Isabelle
    Cassier, Philippe
    Davey, Monica
    Borghaei, Hossein
    Pink, Daniel
    Debiec-Rychter, Maria
    Cheung, Wing
    Bailey, Stuart M.
    Veronese, Maria Luisa
    Reichardt, Annette
    Fumagalli, Elena
    Reichardt, Peter
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (18) : 5910 - 5916
12345